These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cardiovascular effects of low-dose aspirin, traditional non-steroidal anti-inflammatory drugs and coxibs. Patrono C Bull Mem Acad R Med Belg; 2010; 165(1-2):115-23; discussion 124. PubMed ID: 21162342 [No Abstract] [Full Text] [Related]
3. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease. Jaturapatporn D; Isaac MG; McCleery J; Tabet N Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816 [TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory drugs in the 21st century. Rainsford KD Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs. Hermann M; Ruschitzka F Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448 [TBL] [Abstract][Full Text] [Related]
7. How to advise aspirin use in patients who need NSAIDs. Sopena F; Lanas A Curr Pharm Des; 2007; 13(22):2248-60. PubMed ID: 17691998 [TBL] [Abstract][Full Text] [Related]
9. Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs. Thomas D; Ali Z; Zachariah S; Sundararaj KGS; Van Cuyk M; Cooper JC Am J Cardiovasc Drugs; 2017 Oct; 17(5):343-346. PubMed ID: 28353025 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of coxibs. Caporali R; Montecucco C Lupus; 2005; 14(9):785-8. PubMed ID: 16218488 [TBL] [Abstract][Full Text] [Related]
11. [Analgesics, NSAIDS, and coxibs in rheumatic pain]. Di Matteo L Reumatismo; 2006; 58 Spec No.1():84-9. PubMed ID: 23631071 [No Abstract] [Full Text] [Related]
12. Relative cardiovascular and gastrointestinal safety of non-selective non-steroidal anti-inflammatory drugs versus cyclo-oxygenase-2 inhibitors: implications for clinical practice. Patrício JP; Barbosa JP; Ramos RM; Antunes NF; de Melo PC Clin Drug Investig; 2013 Mar; 33(3):167-83. PubMed ID: 23338974 [TBL] [Abstract][Full Text] [Related]
14. Current perspective on the cardiovascular effects of coxibs. Konstam MA; Weir MR Cleve Clin J Med; 2002; 69 Suppl 1():SI47-52. PubMed ID: 12086293 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966 [TBL] [Abstract][Full Text] [Related]
16. [Nonsteroidal anti-inflammatory drugs and glucocorticoids for treatment of connective tissue diseases]. Yamamoto T; Kawai S Nihon Rinsho; 2009 Mar; 67(3):576-81. PubMed ID: 19280935 [TBL] [Abstract][Full Text] [Related]
17. The coxibs and traditional nonsteroidal anti-inflammatory drugs: a current perspective on cardiovascular risks. Cairns JA Can J Cardiol; 2007 Feb; 23(2):125-31. PubMed ID: 17311118 [TBL] [Abstract][Full Text] [Related]
18. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs. Farkouh ME; Greenberg BP Am J Cardiol; 2009 May; 103(9):1227-37. PubMed ID: 19406264 [TBL] [Abstract][Full Text] [Related]
19. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk. Hermann M; Ruschitzka F Intern Med J; 2006 May; 36(5):308-19. PubMed ID: 16650196 [TBL] [Abstract][Full Text] [Related]
20. COX-2 inhibitors and the heart: are all coxibs the same? Sooriakumaran P Postgrad Med J; 2006 Apr; 82(966):242-5. PubMed ID: 16597810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]